Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension
Susan P. Mollan, Clare L. Fraser, Kathleen B. Digre, Hans‐Christoph Diener, Richard B. Lipton, Marianne Juhler, Neil R. Miller, Patricia Pozo‐Rosich, Mansoureh Togha, Kristian Brock, Marc Dinkin, Carmen K. M. Chan, Cristina Tassorelli, Alexandra J. Sinclair, Gisela M. Terwindt, Rigmor Jensen
Abstract
The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.